Veeva price target lowered to $210 from $261 at Truist

TipRanks01-14

Truist analyst Jailendra Singh lowered the firm’s price target on Veeva (VEEV) to $210 from $261 and keeps a Hold rating on the shares as part of a broader research note on the Healthcare Digital/IT ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2503574394?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-14 22:26","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2503574394","market":"us","top_or_hot":-1,"title":"Veeva price target lowered to $210 from $261 at Truist","media":"TipRanks","content":"<div>\n<p>Truist analyst Jailendra Singh lowered the firm’s price target on Veeva (VEEV) to $210 from $261 and keeps a Hold rating on the shares as part of a broader research note on the Healthcare Digital/IT ...</p>\n\n<a href=\"https://finance.yahoo.com/news/veeva-price-target-lowered-210-142619019.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Veeva price target lowered to $210 from $261 at Truist</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVeeva price target lowered to $210 from $261 at Truist\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-01-14 22:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/veeva-price-target-lowered-210-142619019.html><strong>TipRanks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Truist analyst Jailendra Singh lowered the firm’s price target on Veeva (VEEV) to $210 from $261 and keeps a Hold rating on the shares as part of a broader research note on the Healthcare Digital/IT ...</p>\n\n<a href=\"https://finance.yahoo.com/news/veeva-price-target-lowered-210-142619019.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://finance.yahoo.com/news/veeva-price-target-lowered-210-142619019.html","article_id":"2503574394","we_media_id":null,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/veeva-price-target-lowered-210-142619019.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2503574394","pubTimestamp":1736864779,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Truist analyst Jailendra Singh lowered the firm’s price target on Veeva  to $210 from $261 and keeps a Hold rating on the shares as part of a broader research note on the Healthcare Digital/IT sector. According to thej firm’s investor sentiment survey, heading into 2025, only around 35% of investor respondents are bullish on HCIT, 9% bearish, and 56% are neutral, which compares with 56% of investor respondents bullish on HCIT, 6% bearish, and 38% neutral a year ago, the analyst tells investors in a research note. The firm adds however that Digital Health companies are trading at attractive valuations, and the bid-ask spread narrowing, with deal activity also likely picking up in 2025 with the new administration seen as potentially more favorable to M&A.Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener. Veeva price target lowered to $255 from $285 at KeyBan","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"Truist将Veeva目标价从261美元下调至210美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VEEV":1},"content_text":"Truist analyst Jailendra Singh lowered the firm’s price target on Veeva (VEEV) to $210 from $261 and keeps a Hold rating on the shares as part of a broader research note on the Healthcare Digital/IT sector. According to thej firm’s investor sentiment survey, heading into 2025, only around 35% of investor respondents are bullish on HCIT, 9% bearish, and 56% are neutral, which compares with 56% of investor respondents bullish on HCIT, 6% bearish, and 38% neutral a year ago, the analyst tells investors in a research note. The firm adds however that Digital Health companies are trading at attractive valuations, and the bid-ask spread narrowing, with deal activity also likely picking up in 2025 with the new administration seen as potentially more favorable to M&A.\n\nStay Ahead of the Market:\n\nDiscover outperforming stocks and invest smarter with Top Smart Score Stocks\nFilter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener\n\n\n\nPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>\n\n\nSee the top stocks recommended by analysts >>\n\n\nRead More on VEEV:\n\nVeeva named top pick for 2025 at Wells Fargo\nVeeva price target lowered to $255 from $285 at KeyBanc\nVeeva added to Q1 ‘Tactical Ideas List’ at Wells Fargo\nVeeva initiated with an Overweight at Stephens\nVeeva price target raised to $195 from $183 at Morgan Stanley","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.2","shortVersion":"4.30.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2503574394"}